You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Portable Phage Preparation Technology for Field Application

    SBC: CFD RESEARCH CORPORATION            Topic: A20BT023

    Bacteriophages (phages) are becoming important therapeutic candidates against multidrug resistant (MDR) bacterial infections. There is a need to isolate and concentrate phages collected from the field to enhance specimen storage stability for long-distance transport to specialized laboratories for subsequent analysis. Environmental phage preparation requires expensive, bulky instrumentation and in ...

    STTR Phase II 2023 Department of DefenseDefense Health Agency
  2. Modular Continuous Energetic Production System

    SBC: SYNTHIO CHEMICALS INC            Topic: OSD21C003

    This program will develop and demonstrate a novel modular, continuous synthesis platform that can be rapidly reconfigured to produce multiple classes of energetic materials. Continuous synthesis of energetic materials has clear safety advantages, but current approaches are slow to realize due to long process development timelines. The proposed program will develop a system integration and control ...

    STTR Phase II 2023 Department of DefenseOffice of the Secretary of Defense
  3. Flexible Microfluidic Process Technology for Biopharmaceutical Purification of Bacteriophages

    SBC: CFD RESEARCH CORPORATION            Topic: DHA21C002

    Multidrug resistant (MDR) bacterial wound infections remain a persistent challenge for front-line military medical providers in prolonged care treatment. Bacteriophage (phage) therapeutics have demonstrated preclinical and clinical efficacy against ESKAPEE infections. Phage production however remains a challenge to remove common pyrogen contaminants from phage products, including endotoxins (lipop ...

    STTR Phase II 2023 Department of DefenseDefense Health Agency
  4. Atomic fusion wafer bonding tool for ultra-high power switches

    SBC: PARTOW TECHNOLOGIES LLC            Topic: OSD22B004

    Ultra-Wide bandgap materials such as GaN and Ga2O3 are emerging as preferred materials in high power applications due to their high breakdown field. The thermal dissipation is poor in both those materials due to low thermal conductivity. A high thermal conductivity material such as SiC is used as a growing substrate, however, the thermal conductivity is still limited due to defects in the interfac ...

    STTR Phase I 2023 Department of DefenseOffice of the Secretary of Defense
  5. Modular Continuous Energetic Production System

    SBC: SYNTHIO CHEMICALS INC            Topic: OSD21C003

    This program will develop and demonstrate a novel modular, continuous synthesis platform that can be rapidly reconfigured to produce multiple classes of energetic materials. Continuous synthesis of energetic materials has clear safety advantages, but current approaches are slow to realize due to long process development timelines. The proposed program will develop a system integration and control ...

    STTR Phase I 2022 Department of DefenseOffice of the Secretary of Defense
  6. Flexible Microfluidic Process Technology for Biopharmaceutical Purification of Bacteriophages

    SBC: CFD RESEARCH CORPORATION            Topic: DHA21C002

    Multidrug resistant (MDR) bacterial wound infections remain a persistent challenge for front-line military medical providers in prolonged care treatment. Phage therapeutics have demonstrated preclinical and clinical efficacy against ESKAPEE infections. Phage production however remains a challenge to remove bacterial remnants including LPS endotoxins and other pyrogens. To meet regulatory requireme ...

    STTR Phase I 2022 Department of DefenseDefense Health Agency
  7. Develop and demonstrate a technology for isolation of bacteriophages with enhanced antibiofilm activity

    SBC: CFD RESEARCH CORPORATION            Topic: DHA20B003

    The twenty-first century has seen a global rise in bacterial infections exhibiting antimicrobial-resistance (AMR). More than ninety percent of chronic wounds contain microbial biofilms that exhibit AMR, and the bacteria responsible for several of these recalcitrant infections are called ESKAPEE pathogens. Eradicating ESKAPEE pathogenic infections is challenging, but bacteriophage (phage) therapy i ...

    STTR Phase II 2022 Department of DefenseDefense Health Agency
  8. ECCCHO: Effective Combat Casualty Care Handoff Operations

    SBC: TIER 1 PERFORMANCE SOLUTIONS LLC            Topic: DHA17B002

    According to the Joint Commission, approximately 70% of sentinel events in medical care are related to communication mishaps, and despite regular and frequent occurrence, poor communication during patient handoffs (i.e., transfer of patient care information, responsibility, and authority from one provider to another) remains a major contributor to medical errors (Nether, 2017; The Joint Commission ...

    STTR Phase II 2021 Department of DefenseDefense Health Agency
  9. Inspire- In-Mask Sensors for Physiological Investigation of Respiratory Exhalation

    SBC: MAKEL ENGINEERING, INC.            Topic: DHP16C002

    High concentrations of supplemental oxygen are used routinely by pilots and divers prior to and during missions to prevent and treat decompression sickness, avoid detection during covert operations, and to support oxygenation following pulmonary injury. Due to pulmonary oxygen toxicity (PO2T), exposure limits are imposed to prevent damage to pulmonary tissues. Current policy focuses on preventing ...

    STTR Phase II 2021 Department of DefenseDefense Health Agency
  10. CORE-Military: A Virtual Reality Platform for Emergency Care Training and Assessment in Austere Environments

    SBC: Radiant Images Inc.            Topic: DHA20B001

    In emergency medicine, time is a critical factor that can significantly influence the survival of seriously ill patients. Early recognition of clinical deterioration and rapid initial management is paramount in any setting where emergency care is provided. In military medicine and humanitarian care, delivering high quality and timely care to injured patients poses even greater and more complex cha ...

    STTR Phase I 2021 Department of DefenseDefense Health Agency
US Flag An Official Website of the United States Government